期刊文献+

DM2患者HbA_1C与肿瘤标志物的相关性分析 被引量:11

The Correlatinoship Between Blood HbA_1C Levels and Tumor Markers Contents in Patients with Type 2 Diabetes
下载PDF
导出
摘要 目的:分析2型糖尿病(DM2)患者糖化血红蛋白(HbA1C)与血清肿瘤标志物间的相关性。方法:用高压液相色谱法检测HbA1C、电化学发光法检测血清甲胎蛋白(AFP)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)、糖类抗原125(CA125)、糖类抗原15-3(CA15-3)、铁蛋白(Ft)、β2微球蛋白(β2-m),分析112名DM2患者患病时间、HbA1C与肿瘤标志物间的相关性。结果:DM2患者的HbA1C、CA125、CA19-9、Ft的浓度显著高于正常对照组(P<0.05);DM2患者的年龄与AFP、Ft呈显著负相关。患病时间与Ft水平呈显著负相关(P<0.01)。HbA1C水平与CEA、CA125、CA19-9、Ft呈显著正相关(P<0.01,P<0.05,P<0.01,P<0.05)。AFP与CEA、Ft呈显著正相关(P<0.05,P<0.05)。CEA与CA15-3、CA19-9呈显著正相关(P<0.01,P<0.01)。CA125与CA19-9呈显著正相关(P<0.01)。CA15-3与CA19-9呈显著正相关(P<0.01)。结论:DM2患者的血清肿瘤标志物CA125、CA19-9、Ft的水平较正常人组升高。血清肿瘤标志物CEA、CA125、CA19-9、Ft随HbA1C的升高而增加,与患病时间的长短无关。高血糖对血清肿瘤标志物的表达可能有促进作用。 Objective To investigate the correlation ship between blood HbA1C and tumor markers levels in patients with type 2 diabetes. Methods Blood glycosylated haemoglobin (HbA1C) (with high-press liquid chromatograply) and serum tumor markers α-fetoprotein (AFP),carcinoembryonic antigen (CEA),carbohydrate antigen 125 (CA125),carbohydrate antigen 15-3 (CA15-3),carbohydrate antigen19-9 (CA19-9),ferritin (Ft) (with CLIA) were determined in 112 cases of type 2 diabetes (DM2) and 38 controls. Results The levels of HbA1C,CA125,CA19-9,Ft in patients were significantly higher than those in controls (P0.05). The duration of disease was significantly positively correlated with the concentration of Ft (P0.01),but was not correlated with AFP,CEA,CA125,CA15-3,CA19-9 levels HbA1C were significantly positively correlated with CEA,CA125,CA19-9,Ft (P0.01,P0.05,P0.01,P0.05). AFP levels were significantly positively correlated with CEA,Ft (P0.05,P0.05). CEA significantly positively correlated with CA15-3,CA19-9 (P0.01,P0.01). CA125 significantly positively correlated with CA19-9 (P0.01). CA15-3 significantly positively correlated with CA19-9 (P0.01). Conclusion The levels of tumor marker CA125,CA19-9,Ft in patients with DM2 were increased. The concentration of CEA,CA125,CA19-9,Ft in DM2 patients increase along with the increase of levels of HbA1C,but it were not affected by duration of the disease. High glucose might promote the expression of tumor markers in patients with DM2.
出处 《放射免疫学杂志》 CAS 2010年第2期195-197,共3页 Journal of Radioimmanology
关键词 糖化血红蛋白 肿瘤标志物 相关性 glycosylated haemoglobin tumor marker correlation
  • 相关文献

参考文献6

  • 1Gullo L, Pezzilli R, Morselli LAM. Diabetes and the risk of pancreatic cancer. Italian pancreatic cancer study group [ J ]. N Engl J Med, 1994. 331, 81-84.
  • 2Moss EL, Hollingworth J. The role of CA125 in clinical practice[J].Clin Pathol, 2005,58(3) :308-312.
  • 3万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 4Haglund C, Lundin J, Kuuseda D, et al. CA242 a new tumor marker for pancreatic cancer[J]. Br J Cancer,1994,70:487.
  • 5陈瑜,王磊,赵允文.血清CA19-9的酶免测定及临床应用[J].中国肿瘤临床,1997,24(6):408-410. 被引量:25
  • 6Chart ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes : a population-based study [ J ]. Gastroenterology, 2005, 129:504-511.

二级参考文献1

  • 1齐为民,国外医学临床生物化学与检验学分册,1994年,15卷,2期,56页

共引文献203

同被引文献72

  • 1Julia B Greer,Mark H Yazer,Jay S Raval,M Michael Barmada,Randall E Brand,David C Whitcomb.Significant association between ABO blood group and pancreatic cancer[J].World Journal of Gastroenterology,2010,16(44):5588-5591. 被引量:10
  • 2付煜,沈华,公益明,邱宁岩,张静馨,李惠萍.南京市1928例单位体检人群AFP、CEA、PSA检测分析[J].南京医科大学学报(自然科学版),2007,27(2):202-203. 被引量:6
  • 3叶小龙,王长江,林刚,曹永红,代芳.Visfatin在2型糖尿病患者腹部皮下和网膜脂肪组织中的表达及其与胰岛素抵抗的关系[J].安徽医科大学学报,2007,42(2):205-207. 被引量:17
  • 4Haider DG, Schindler K, Schaller G, et al.Increased plasma vis- fatin concentrations in morbidly obese subjects are reduced af- ter gastric banding.J Clin Endocrinol Metab,2006,91 (4): 1578-1581.
  • 5Katsuki A,Urakawa H,Gabazza EC,et al.Circulating levels of active ghrelin is associated with abdominal adiposity,hyperin- sulinemia and insulin resistance in patients with type 2 diabetes mellitus.Eur J Endocrinol, 2004, 151 (5) : 573-577.
  • 6陈灏珠,董强.实用内科学[M].12版.北京:人民卫生出版社,2005:2669-2670
  • 7Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量:64
  • 8Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I ( IGF-I ), IGF binding proteins, their biologic interactions, and colorectal Cancer [ J ] . J Natl Cancer lnst, 2002, 94 ( 13 ) : 972-980.
  • 9Meyskens FL Jr, Curt GA, Brenner DE. Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic[J]. Cancer Prey Res Phila, 2011, 4 (3) : 311 -323.
  • 10Guo Q, Kang M, Zhang B, et al. Elevated levels of CA199 and CEA in pancreatic cancer-associated diabetes [ J ]. J Cancer Res Clin Oneol, 2010, 136(11) : 1627 - 1631.

引证文献11

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部